Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 11 studies | 35% ± 17% | |
glutamatergic neuron | 7 studies | 36% ± 12% | |
endothelial cell | 5 studies | 28% ± 11% | |
epithelial cell | 5 studies | 36% ± 14% | |
astrocyte | 5 studies | 28% ± 11% | |
fibroblast | 4 studies | 24% ± 10% | |
type I pneumocyte | 4 studies | 19% ± 4% | |
GABAergic neuron | 4 studies | 32% ± 12% | |
interneuron | 4 studies | 43% ± 20% | |
plasma cell | 3 studies | 22% ± 8% | |
basal cell | 3 studies | 34% ± 17% | |
goblet cell | 3 studies | 29% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1260.23 | 180 / 180 | 100% | 17.27 | 430 / 430 |
uterus | 100% | 1538.28 | 170 / 170 | 100% | 20.83 | 459 / 459 |
esophagus | 100% | 1148.15 | 1444 / 1445 | 100% | 14.54 | 183 / 183 |
prostate | 100% | 2222.72 | 245 / 245 | 100% | 14.55 | 500 / 502 |
skin | 100% | 1425.46 | 1809 / 1809 | 100% | 12.11 | 470 / 472 |
intestine | 100% | 1331.44 | 966 / 966 | 99% | 13.03 | 524 / 527 |
breast | 100% | 1317.85 | 459 / 459 | 99% | 14.03 | 1108 / 1118 |
lung | 100% | 1414.47 | 577 / 578 | 99% | 14.27 | 1146 / 1155 |
thymus | 100% | 2018.70 | 653 / 653 | 99% | 12.30 | 599 / 605 |
bladder | 100% | 1120.33 | 21 / 21 | 99% | 17.98 | 499 / 504 |
pancreas | 100% | 931.59 | 328 / 328 | 99% | 13.05 | 176 / 178 |
stomach | 100% | 955.13 | 359 / 359 | 99% | 12.65 | 282 / 286 |
brain | 97% | 819.62 | 2573 / 2642 | 100% | 10.95 | 704 / 705 |
kidney | 100% | 1399.79 | 89 / 89 | 97% | 11.08 | 874 / 901 |
adrenal gland | 100% | 1007.66 | 258 / 258 | 95% | 7.77 | 218 / 230 |
liver | 100% | 987.38 | 226 / 226 | 91% | 8.03 | 370 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.42 | 29 / 29 |
spleen | 100% | 2379.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.57 | 1 / 1 |
adipose | 100% | 970.49 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 766.93 | 1329 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1190.43 | 915 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 7.56 | 78 / 80 |
heart | 96% | 496.97 | 827 / 861 | 0% | 0 | 0 / 0 |
muscle | 86% | 355.42 | 689 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902231 | Biological process | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0006281 | Biological process | DNA repair |
GO_0006974 | Biological process | DNA damage response |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0031573 | Biological process | mitotic intra-S DNA damage checkpoint signaling |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_0000076 | Biological process | DNA replication checkpoint signaling |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030896 | Cellular component | checkpoint clamp complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008408 | Molecular function | 3'-5' exonuclease activity |
GO_0008311 | Molecular function | double-stranded DNA 3'-5' DNA exonuclease activity |
GO_0017124 | Molecular function | SH3 domain binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | RAD9A |
Protein name | Cell cycle checkpoint control protein RAD9A (hRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A) RAD9 checkpoint clamp component A RAD9 homolog A (S. pombe) |
Synonyms | |
Description | FUNCTION: Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair . The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex . Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER) . The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates . The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase . RAD9A possesses 3'->5' double stranded DNA exonuclease activity . . |
Accessions | ENST00000544620.5 ENST00000542139.1 F5H492 F5H8A2 ENST00000307980.7 Q99638 ENST00000538013.5 ENST00000621995.1 A0A0G2JMD0 C4TNW8 F5H4F1 C4TNW7 |